These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

375 related items for PubMed ID: 19457058

  • 1. Apolipoprotein M predicts pre-beta-HDL formation: studies in type 2 diabetic and nondiabetic subjects.
    Plomgaard P, Dullaart RP, de Vries R, Groen AK, Dahlbäck B, Nielsen LB.
    J Intern Med; 2009 Sep; 266(3):258-67. PubMed ID: 19457058
    [Abstract] [Full Text] [Related]

  • 2. Cellular cholesterol efflux to plasma from proteinuric patients is elevated and remains unaffected by antiproteinuric treatment.
    Vogt L, Laverman GD, van Tol A, Groen AK, Navis G, Dullaart RP.
    Nephrol Dial Transplant; 2006 Jan; 21(1):101-6. PubMed ID: 16141462
    [Abstract] [Full Text] [Related]

  • 3. A low-saturated-fat, low-cholesterol diet decreases plasma CETP activity and pre beta-HDL formation but does not affect cellular cholesterol efflux to plasma from type 1 diabetic patients.
    De Vries R, Beusekamp BJ, Kerstens MN, Groen AK, Van Tol A, Dullaart RP.
    Scand J Clin Lab Invest; 2005 Jan; 65(8):729-37. PubMed ID: 16319046
    [Abstract] [Full Text] [Related]

  • 4. Increased cholesterol efflux from cultured fibroblasts to plasma from hypertriglyceridemic type 2 diabetic patients: roles of pre beta-HDL, phospholipid transfer protein and cholesterol esterification.
    de Vries R, Groen AK, Perton FG, Dallinga-Thie GM, van Wijland MJ, Dikkeschei LD, Wolffenbuttel BH, van Tol A, Dullaart RP.
    Atherosclerosis; 2008 Feb; 196(2):733-41. PubMed ID: 17275009
    [Abstract] [Full Text] [Related]

  • 5. Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol.
    Dullaart RP, Groen AK, Dallinga-Thie GM, de Vries R, Sluiter WJ, van Tol A.
    Eur J Endocrinol; 2008 Jan; 158(1):53-60. PubMed ID: 18166817
    [Abstract] [Full Text] [Related]

  • 6. Plasma apolipoprotein M is reduced in metabolic syndrome but does not predict intima media thickness.
    Dullaart RP, Plomgaard P, de Vries R, Dahlbäck B, Nielsen LB.
    Clin Chim Acta; 2009 Aug; 406(1-2):129-33. PubMed ID: 19539616
    [Abstract] [Full Text] [Related]

  • 7. Reverse modulation of the HDL anionic peptide factor and phospholipid transfer protein activity in coronary artery disease and type 2 diabetes mellitus.
    Attia N, Domingo N, Lorec AM, Nakbi A, Hammami S, Ben Hamda K, Portugal H, Lairon D, Hammami M, Chanussot F.
    Clin Biochem; 2009 Jun; 42(9):845-51. PubMed ID: 19135989
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cholesterol efflux from macrophage foam cells is enhanced by active phospholipid transfer protein through generation of two types of acceptor particles.
    Vikstedt R, Metso J, Hakala J, Olkkonen VM, Ehnholm C, Jauhiainen M.
    Biochemistry; 2007 Oct 23; 46(42):11979-86. PubMed ID: 17900150
    [Abstract] [Full Text] [Related]

  • 12. Phospholipid transfer protein activity is determined by type 2 diabetes mellitus and metabolic syndrome, and is positively associated with serum transaminases.
    Dullaart RP, de Vries R, Dallinga-Thie GM, Sluiter WJ, van Tol A.
    Clin Endocrinol (Oxf); 2008 Mar 23; 68(3):375-81. PubMed ID: 17877759
    [Abstract] [Full Text] [Related]

  • 13. Plasma pre beta-HDL formation is decreased by atorvastatin treatment in type 2 diabetes mellitus: Role of phospholipid transfer protein.
    Dallinga-Thie GM, van Tol A, Dullaart RP, Diabetes Atorvastatin lipid intervention (DALI) study group.
    Biochim Biophys Acta; 2009 Aug 23; 1791(8):714-8. PubMed ID: 19303940
    [Abstract] [Full Text] [Related]

  • 14. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis.
    Wolfrum C, Poy MN, Stoffel M.
    Nat Med; 2005 Apr 23; 11(4):418-22. PubMed ID: 15793583
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Post-heparin plasma lipoprotein lipase, but not hepatic lipase activity, is related to plasma adiponectin in type 2 diabetic patients and healthy subjects.
    De Vries R, Wolffenbuttel BH, Sluiter WJ, van Tol A, Dullaart RP.
    Clin Lab; 2005 Apr 23; 51(7-8):403-9. PubMed ID: 16122151
    [Abstract] [Full Text] [Related]

  • 17. Pre-β-HDL formation relates to high-normal free thyroxine in type 2 diabetes mellitus.
    van Tienhoven-Wind LJ, Perton FG, Dullaart RP.
    Clin Biochem; 2016 Jan 23; 49(1-2):41-6. PubMed ID: 26320015
    [Abstract] [Full Text] [Related]

  • 18. Association of apolipoprotein M with high-density lipoprotein kinetics in overweight-obese men.
    Ooi EM, Watts GF, Chan DC, Nielsen LB, Plomgaard P, Dahlbäck B, Barrett PH.
    Atherosclerosis; 2010 May 23; 210(1):326-30. PubMed ID: 20031132
    [Abstract] [Full Text] [Related]

  • 19. Effect of niacin on preβ-1 high-density lipoprotein levels in diabetes.
    Pan J, Shilian P, Ishida B, Wu X, Kane JP, Malloy MJ, Charles MA.
    Metabolism; 2011 Feb 23; 60(2):292-7. PubMed ID: 20303127
    [Abstract] [Full Text] [Related]

  • 20. A prospective evaluation of apolipoprotein M gene T-778C polymorphism in relation to coronary artery disease in Han Chinese.
    Jiao GQ, Yuan ZX, Xue YS, Yang CJ, Lu CB, Lu ZQ, Xiao MD.
    Clin Biochem; 2007 Oct 23; 40(15):1108-12. PubMed ID: 17674965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.